Cas:34576-92-6 3-chloro-6-fluorobenzo(b)thiophene-2-ca& manufacturer & supplier

Chemical Name:3-chloro-6-fluorobenzo(b)thiophene-2-ca&

CAS.NO:34576-92-6

Synonyms:3-Chlor-6-fluorbenzo<b>thiophen-2-carbonsaeure;MFCD00228531

Molecular Formula:C₉H₄ClFO₂S

Molecular Weight:230.64300

HS Code:2934999090

Physical and Chemical Properties:

Melting point:293-297ºC(lit.)

Boiling point:398.2ºC at 760mmHg

Density:N/A

Index of Refraction:

PSA:65.54000

Exact Mass:229.96000

LogP:3.39200

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:NONH for all modes of transpor

Packing Group:

Contact us for information like 3-Chlor-6-fluorbenzo&lt chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,MFCD00228531 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,thiophen-2-carbonsaeure Use and application,3-Chlor-6-fluorbenzo&lt technical grade,usp/ep/jp grade.

Related News: The technology supports breakthroughs in medical research and is widely used by major global pharmaceutical companies to advance drug discovery & development and provide data to support regulatory submissions. 3-chloro-6-fluorobenzo(b)thiophene-2-ca& manufacturer Analysts at Jefferies, meanwhile, said the FDA accelerated approval for Aduhelm, which was based on a surrogate endpoint of amyloid beta plaque reduction (and not clinical benefit) “has implications for ongoing AD studies,” most notably, it reckons, for Roche’s phase 3 GRADUATE test for its anti-amyloid-beta candidate gantenerumab, “as a much lower hurdle than demonstrating clear cognitive benefit” has now become precedent. Jefferies, still cautious, said it remains “unclear what stance FDA may take for the field if GRADUATE fails on cognition despite significant Abeta reductions,” but says it’s probably not going to revive Roche-AC Immune’s anti-amyloid-beta candidate crenezumab, which saw its late-stage CREAD trials discontinued for futility but which is currently in an Alzheimer’s prevention study. 3-chloro-6-fluorobenzo(b)thiophene-2-ca& supplier Adding Darzalex to Bristol Myers Squibb’s Revlimid and steroid dexamethasone (Rd) could slash the risk of death by 32% in newly diagnosed multiple myeloma patients ineligible to receive stem cell transplants, J&J reported at the European Hematology Association’s virtual congress. 3-chloro-6-fluorobenzo(b)thiophene-2-ca& vendor In its message to the public, the FDA said that a person should consider being retested if they used Innova’s diagnostic within the past two weeks. 3-chloro-6-fluorobenzo(b)thiophene-2-ca& factory Adding Darzalex to Bristol Myers Squibb’s Revlimid and steroid dexamethasone (Rd) could slash the risk of death by 32% in newly diagnosed multiple myeloma patients ineligible to receive stem cell transplants, J&J reported at the European Hematology Association’s virtual congress.